FDA Approves Duvelisib for CLL/SLL, FL
ACCC Submits Comments to Proposed 2019 OPPS Rule
Pfizer Announces Relief for Cancer Patients Affected by Hurricane Florence
Hogan Lovells to Host Webinar on Legal Considerations of Telehealth
CMS Issues CY 2019 Proposed Rule Aimed at Efficiency, Transparency, Clinician Burden
House of Representatives Passes Transparency Reforms to Medicare LCDs
FDA Approves New Treatment for Hairy Cell Leukemia
CMS Supports North Carolina and South Carolina Ahead of Hurricane Florence
AACR Releases Annual Cancer Progress Report
ACCC Submits Comments to CY2019 Proposed PFS Rule
Three Foundations Commit 30 Million Dollars to Nonprofit Generic Drug Company
CMS Issues Changes to Part D Formulary Options in 2020
FDA Approves Ibrutinib Plus Rituximab for Rare Blood Cancer
FDA Approves Pembrolizumab + Chemotherapy for NSqNSCLC
FDA Updates Prescribing Information for Keytruda and Tecentriq
FDA Approves Nivolumab for Previously Treated SCLC Patients
FDA Approves Lenvatinib for Unresectable Hepatocellular Carcinoma
HealthWell Foundation Opens Fund for Gastric Cancer Patients
NCCN Publishes Guidelines for Rare Cancers Associated with Pregnancy
FDA Approves Mogamulizumab-kpkc for Mycosis Fungoides, Sézary Syndrome
CMS Gives Medicare Advantage Plans Option to Utilize Step Therapy
FDA Warns Against Long-Term Azithromycin Use for Lung Condition in Cancer Patients
CMS to Hold 8/22 Listening Session on Understanding CY 2019 PFS Proposed Rule
FDA Approves Lusutrombopag for Thromocytopenia
